Enhanced expression of soluble antibody fragments by low-temperature and overdosing with a nitrogen source

Se Jun Kim, Gyong Sik Ha, Gyunghwa Lee, Sung In Lim, Chung Min Lee, Yoo Hee Yang, Jae Min Lee, Ju Eun Kim, Jae Hee Lee, Yong Uk Shin, Chan Wha Kim, Dong Eok Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Escherichia coli has been a primary host for the prokaryotic production of antibody fragments (Fabs) and has contributed to several successes in the pharmaceutical industry. Nevertheless, the requirement of disulfide bonds often results in low-yield fermentation and a lack of cost-effectiveness. Despite the improved production of functional Fabs by fermentation below 30 °C, the limited cellular growth needs further work. To address these issues, we investigated the effect of nitrogen supply on the cellular growth and the Fab productivity. We used the anti-human VEGF-A Fab as a model that exhibited poor expression at 37 °C regardless of the amount of nitrogen supplied during fermentation. In stark contrast, the expression yield of soluble Fab with a gross nitrogen supply of 6.91 g/L of broth throughout the fermentation at 25 °C was 332 mg/L. Furthermore, and increased nitrogen supply of 10.9 g/L significantly improved the yield of active form by 59.7% and the cellular growth rate by 39.3%. These results indicate that overdosing of a nitrogen source at low temperature is critical to Fab productivity in E. coli.

Original languageEnglish
Pages (from-to)9-15
Number of pages7
JournalEnzyme and Microbial Technology
Volume115
DOIs
Publication statusPublished - 2018 Aug 1

Fingerprint

Immunoglobulin Fragments
Nitrogen
Fermentation
Temperature
Escherichia coli
Growth
Productivity
Drug Industry
Cost effectiveness
Disulfides
Vascular Endothelial Growth Factor A
Cost-Benefit Analysis
Pharmaceutical Preparations
Industry

Keywords

  • Antibody fragment
  • Fed-batch fermentation
  • Low-temperature
  • Nitrogen effect
  • Soluble Fab

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Applied Microbiology and Biotechnology

Cite this

Enhanced expression of soluble antibody fragments by low-temperature and overdosing with a nitrogen source. / Kim, Se Jun; Ha, Gyong Sik; Lee, Gyunghwa; Lim, Sung In; Lee, Chung Min; Yang, Yoo Hee; Lee, Jae Min; Kim, Ju Eun; Lee, Jae Hee; Shin, Yong Uk; Kim, Chan Wha; Lee, Dong Eok.

In: Enzyme and Microbial Technology, Vol. 115, 01.08.2018, p. 9-15.

Research output: Contribution to journalArticle

Kim, SJ, Ha, GS, Lee, G, Lim, SI, Lee, CM, Yang, YH, Lee, JM, Kim, JE, Lee, JH, Shin, YU, Kim, CW & Lee, DE 2018, 'Enhanced expression of soluble antibody fragments by low-temperature and overdosing with a nitrogen source', Enzyme and Microbial Technology, vol. 115, pp. 9-15. https://doi.org/10.1016/j.enzmictec.2018.04.002
Kim, Se Jun ; Ha, Gyong Sik ; Lee, Gyunghwa ; Lim, Sung In ; Lee, Chung Min ; Yang, Yoo Hee ; Lee, Jae Min ; Kim, Ju Eun ; Lee, Jae Hee ; Shin, Yong Uk ; Kim, Chan Wha ; Lee, Dong Eok. / Enhanced expression of soluble antibody fragments by low-temperature and overdosing with a nitrogen source. In: Enzyme and Microbial Technology. 2018 ; Vol. 115. pp. 9-15.
@article{7d220cd9f33b4f1db0ba370701c49c46,
title = "Enhanced expression of soluble antibody fragments by low-temperature and overdosing with a nitrogen source",
abstract = "Escherichia coli has been a primary host for the prokaryotic production of antibody fragments (Fabs) and has contributed to several successes in the pharmaceutical industry. Nevertheless, the requirement of disulfide bonds often results in low-yield fermentation and a lack of cost-effectiveness. Despite the improved production of functional Fabs by fermentation below 30 °C, the limited cellular growth needs further work. To address these issues, we investigated the effect of nitrogen supply on the cellular growth and the Fab productivity. We used the anti-human VEGF-A Fab as a model that exhibited poor expression at 37 °C regardless of the amount of nitrogen supplied during fermentation. In stark contrast, the expression yield of soluble Fab with a gross nitrogen supply of 6.91 g/L of broth throughout the fermentation at 25 °C was 332 mg/L. Furthermore, and increased nitrogen supply of 10.9 g/L significantly improved the yield of active form by 59.7{\%} and the cellular growth rate by 39.3{\%}. These results indicate that overdosing of a nitrogen source at low temperature is critical to Fab productivity in E. coli.",
keywords = "Antibody fragment, Fed-batch fermentation, Low-temperature, Nitrogen effect, Soluble Fab",
author = "Kim, {Se Jun} and Ha, {Gyong Sik} and Gyunghwa Lee and Lim, {Sung In} and Lee, {Chung Min} and Yang, {Yoo Hee} and Lee, {Jae Min} and Kim, {Ju Eun} and Lee, {Jae Hee} and Shin, {Yong Uk} and Kim, {Chan Wha} and Lee, {Dong Eok}",
year = "2018",
month = "8",
day = "1",
doi = "10.1016/j.enzmictec.2018.04.002",
language = "English",
volume = "115",
pages = "9--15",
journal = "Enzyme and Microbial Technology",
issn = "0141-0229",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Enhanced expression of soluble antibody fragments by low-temperature and overdosing with a nitrogen source

AU - Kim, Se Jun

AU - Ha, Gyong Sik

AU - Lee, Gyunghwa

AU - Lim, Sung In

AU - Lee, Chung Min

AU - Yang, Yoo Hee

AU - Lee, Jae Min

AU - Kim, Ju Eun

AU - Lee, Jae Hee

AU - Shin, Yong Uk

AU - Kim, Chan Wha

AU - Lee, Dong Eok

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Escherichia coli has been a primary host for the prokaryotic production of antibody fragments (Fabs) and has contributed to several successes in the pharmaceutical industry. Nevertheless, the requirement of disulfide bonds often results in low-yield fermentation and a lack of cost-effectiveness. Despite the improved production of functional Fabs by fermentation below 30 °C, the limited cellular growth needs further work. To address these issues, we investigated the effect of nitrogen supply on the cellular growth and the Fab productivity. We used the anti-human VEGF-A Fab as a model that exhibited poor expression at 37 °C regardless of the amount of nitrogen supplied during fermentation. In stark contrast, the expression yield of soluble Fab with a gross nitrogen supply of 6.91 g/L of broth throughout the fermentation at 25 °C was 332 mg/L. Furthermore, and increased nitrogen supply of 10.9 g/L significantly improved the yield of active form by 59.7% and the cellular growth rate by 39.3%. These results indicate that overdosing of a nitrogen source at low temperature is critical to Fab productivity in E. coli.

AB - Escherichia coli has been a primary host for the prokaryotic production of antibody fragments (Fabs) and has contributed to several successes in the pharmaceutical industry. Nevertheless, the requirement of disulfide bonds often results in low-yield fermentation and a lack of cost-effectiveness. Despite the improved production of functional Fabs by fermentation below 30 °C, the limited cellular growth needs further work. To address these issues, we investigated the effect of nitrogen supply on the cellular growth and the Fab productivity. We used the anti-human VEGF-A Fab as a model that exhibited poor expression at 37 °C regardless of the amount of nitrogen supplied during fermentation. In stark contrast, the expression yield of soluble Fab with a gross nitrogen supply of 6.91 g/L of broth throughout the fermentation at 25 °C was 332 mg/L. Furthermore, and increased nitrogen supply of 10.9 g/L significantly improved the yield of active form by 59.7% and the cellular growth rate by 39.3%. These results indicate that overdosing of a nitrogen source at low temperature is critical to Fab productivity in E. coli.

KW - Antibody fragment

KW - Fed-batch fermentation

KW - Low-temperature

KW - Nitrogen effect

KW - Soluble Fab

UR - http://www.scopus.com/inward/record.url?scp=85045422054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045422054&partnerID=8YFLogxK

U2 - 10.1016/j.enzmictec.2018.04.002

DO - 10.1016/j.enzmictec.2018.04.002

M3 - Article

C2 - 29859607

AN - SCOPUS:85045422054

VL - 115

SP - 9

EP - 15

JO - Enzyme and Microbial Technology

JF - Enzyme and Microbial Technology

SN - 0141-0229

ER -